Editors’ Picks: April Highlights from AACR Journals
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Progress Against Cancer
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment...
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of...
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
Researchers are striving to understand why men are more likely than women to get and die from many types...